A prospective randomized trial of doxorubicin versus idarubicin in the treatment of advanced breast cancer.

MLA

Lopez, Massimo, et al. “A Prospective Randomized Trial of Doxorubicin versus Idarubicin in the Treatment of Advanced Breast Cancer.” Cancer (0008543X), vol. 64, no. 12, Dec. 1989, pp. 2431–36. EBSCOhost, https://doi.org/10.1002/1097-0142(19891215)64:12<2431::AID-CNCR2820641206>3.0.CO;2-1.

APA

Lopez, M., Contegiacomo, A., Vici, P., Dello Ioio, C., Di Lauro, L., Pagliarulo, C., Carpano, S., Giannarelli, D., De Placido, S., Fazio, S., Bianco, A. R., Lopez, M., Contegiacomo, A., Vici, P., Dello Ioio, C., Di Lauro, L., Pagliarulo, C., Carpano, S., Giannarelli, D., & De Placido, S. (1989). A prospective randomized trial of doxorubicin versus idarubicin in the treatment of advanced breast cancer. Cancer (0008543X), 64(12), 2431–2436. https://doi.org/10.1002/1097-0142(19891215)64:12<2431::AID-CNCR2820641206>3.0.CO;2-1

Chicago

Lopez, Massimo, Alma Contegiacomo, Patrizia Vici, Concetta Dello Ioio, Luigi Di Lauro, Clorindo Pagliarulo, Silvia Carpano, et al. 1989. “A Prospective Randomized Trial of Doxorubicin versus Idarubicin in the Treatment of Advanced Breast Cancer.” Cancer (0008543X) 64 (12): 2431–36. doi:10.1002/1097-0142(19891215)64:12<2431::AID-CNCR2820641206>3.0.CO;2-1.